Skip to content

SUPERA S-60-030-120-P6Recalls & reported problems

Abbott Vascular Inc. · Supera Peripheral Stent System 6 mm x 30 mm x 120 cm 6 F · Class 3 · Implant

All models of SUPERA (55)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
3
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 08717648211881), received between Aug 30, 2016 and Dec 30, 2025 — classified as 1 injury, 2 malfunctions.

The most frequently reported specific device problem is “Difficult or Delayed Activation” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 1 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1
  • Difficult or Delayed Activation1
  • Material Separation1
  • Physical Resistance/Sticking1

Patient problems

  • Insufficient Information1
  • No Clinical Signs, Symptoms or Conditions1
  • Stenosis1

Recent adverse event reports

The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.

  • MalfunctionDec 30, 2025Difficult or Delayed Activation; Physical Resistance/Sticking; Difficult or Delayed Activation; Physical Resistance/Sticking

    IT WAS REPORTED THAT THE PROCEDURE PERFORMED WAS TO TREAT THE LEFT ANTERIOR TIBIAL ARTERY. THE RATCHET [THUMBSLIDE] WAS NOT CATCHING THE DEVICE AND DIFFICULTY WAS NOTED DURING DEPLOYMENT OF THE 6.0X30MM SUPERA SELF-EXPANDING STENT OVER A 0.018 GUIDEWIRE. AFTER MANIPULATION WITH THE CATHETER, THE SES WAS ABLE TO FULLY DEPLOY. THERE WERE NO ADVERSE PATIENT EFFECTS AND NO CLINICALLY SIGNIFICANT DELAY IN THE PROCEDURE. NO ADDITIONAL INFORMATION WAS PROVIDED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 23928774 ↗
  • MalfunctionFeb 4, 2021Material Separation; Material Separation

    IT WAS REPORTED THAT THE PROCEDURE WAS PERFORMED TO TREAT A NON-CALCIFIED, MILDLY TORTUOUS RIGHT SUPERFICIAL FEMORAL ARTERY. PRE-DILATATION WAS DONE WITH A 6.0X40MM ARMADA 18 BALLOON INFLATED TO NOMINAL AT 8ATM FOR 2 MINUTES. THE 6.0X30MM SUPERA SELF-EXPANDING STENT SYSTEM (SESS) WAS ADVANCED USING A 6F SHEATH (55CM), UP AND OVER THE ILIAC, WITH NO RESISTANCE. THEN UPON DEPLOYMENT, IT WAS OBSERVED UNDER FLUOROSCOPY THAT THE NOSE CONE WAS STARTING TO BECOME DETACHED. THEREFORE, THE PHYSICIAN QUICKLY FINISHED DEPLOYING THE STENT AND A DECISION WAS MADE TO RETRACT THE THUMB SLIDE BACK TO REMOVE THE SYSTEM WITH THE GUIDEWIRE AS A SINGLE UNIT. AFTER THE DEVICES WERE SUCCESSFULLY REMOVED FROM THE PATIENT, THE PHYSICIAN PULLED ON THE NOSE CONE AND IT BECAME EASILY FULLY DETACHED. THE TARGET LESION WAS TREATED. THE PATIENT IS STABLE. NO OTHER ISSUES NOTED. THERE WERE NO ADVERSE PATIENT EFFECTS AND NO CLINICALLY SIGNIFICANT DELAY IN THE PROCEDURE. NO ADDITIONAL INFORMATION WAS PROVIDED.

    Patient problems: Insufficient Information

    MAUDE report 11280237 ↗
  • InjuryAug 30, 2016Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT ON (B)(6) 2016 THREE SUPERA STENTS WERE DEPLOYED IN THE SUPERFICIAL FEMORAL ARTERY. DUE TO RESTENOSIS OBSERVED IN THE PREVIOUSLY TREATED AREA, THE PATIENT UNDERWENT REVASCULARIZATION ON (B)(6) 2016. NO ADDITIONAL INFORMATION WAS PROVIDED.

    Patient problems: Stenosis

    MAUDE report 5914943 ↗

Other STENT, SUPERFICIAL FEMORAL ARTERY devices

All STENT, SUPERFICIAL FEMORAL ARTERY devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page